NCQM — National Committee for Quality Management

Search NCQM

Recognition or voluntary program

FDA Recognized Consensus Standards for Medical Devices

FDA recognizes consensus standards for specified uses in medical device premarket review. The recognition record identifies the standard and relevant conditions, including complete or partial recognition. Recognition is distinct from incorporation into regulation and from approval or clearance of a device. A manufacturer must connect the selected edition and recognized provisions to the intended device and the evidence submitted.

Reference
FD&C Act section 514(c); FDA Recognized Consensus Standards Database
Source authority
Food and Drug Administration
Legal character
FDA recognition supports defined uses of consensus standards in device submissions; use is generally voluntary unless a separate requirement makes the standard binding.

Define the device and technical question

Begin with the device, intended use and characteristic that requires evidence. A standard may address terminology, a test method, a performance characteristic or a broader system. Its relevance depends on the device and submission. Recognition does not establish that every part of the standard applies to every device within a broad commercial category.

Read the recognition record

FDA’s database identifies recognized standards and associated information. Examine the designation, edition, recognition number and any supplemental information. Complete and partial recognition have different implications. Review exclusions, limitations and transition information in the actual record rather than treating the presence of a standard’s title in a search result as unrestricted recognition of all provisions.

Separate recognition from binding adoption

Consensus standards are generally used voluntarily in this context. A separate regulation can incorporate a standard or establish a mandatory performance requirement. Those obligations must be assessed through the adopting provision. QMSR incorporation of ISO 13485:2016, for example, should not be confused with the general voluntary recognition pathway for standards supporting a device submission.

Connect the evidence to the declared scope

Where the submission uses a declaration of conformity, examine FDA’s conditions for that use and the recognized scope. NCQM practice consideration: connect the claimed provisions to the test reports, analyses and device configuration. Identify deviations and provisions not addressed. A laboratory report to a standard does not by itself explain the scope of a manufacturer’s declaration.

Control editions and changes

A publisher’s new edition does not automatically replace the edition FDA recognizes. Check the current recognition record and any transition or withdrawal conditions. Internally, retain the edition used for testing and assess changes in methods, criteria or scope. A report to an older edition may contain useful data without supporting an unrestricted statement of conformity to a newer one.

Keep the product conclusion bounded

Recognition of a standard is not FDA certification of a laboratory, manufacturer or product. It also does not replace the applicable submission pathway, labeling, quality system or postmarket duties. Use the recognition record with the device’s requirement register and submission strategy, then retain the basis for the technical conclusion and the source-check date.

Official sources

Sources checked 2026-10-19. This is the review date for this profile, separate from any legal effective or compliance date.

  1. Agency recognition framework

    FDA Division of Standards and Conformity Assessment

    www.fda.gov

  2. Official recognition records

    FDA Recognized Consensus Standards Database

    www.accessdata.fda.gov

How these profiles are prepared · Request a correction

Practice guidance